Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant in Improving Motor-Sleep Comorbidity in Parkinson's Disease
NCT07384429Phase 4Not yet recruiting
- Sponsor
- YangPan
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lemborexant in Parkinson's disease (PD), Insomnia, sponsored by YangPan. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
Parkinson's disease (PD)Insomnia
Beyond the preview
Go deeper on NCT07384429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384429.